Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study.
| Author | |
|---|---|
| Abstract | :
The goal of this study was to identify serum markers that are modulated by treatment with golimumab with or without methotrexate (MTX) and are associated with clinical response. |
| Year of Publication | :
2011
|
| Journal | :
Arthritis research & therapy
|
| Volume | :
12
|
| Issue | :
6
|
| Number of Pages | :
R211
|
| Date Published | :
2010
|
| ISSN Number | :
1478-6354
|
| URL | :
http://arthritis-research.com/content/12/6/R211
|
| DOI | :
10.1186/ar3188
|
| Short Title | :
Association of serum markers with improvement in clinical respon
|
| Download citation |